Illumina, Inc

ISIN US4523271090 Symbol ILMN Industry Diagnostics & Research Sector Healthcare
Illumina Price
493.0USD 0.56%
1y Low: 251.1
1y High: 508.4
1y Low: 251.1
1y High: 508.4
Illumina Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
illumina.com
Market Cap
58.2 B USD
Dividend Yield
Performance 1y
82.50 %
PER
89.7

Illumina Stock Chart

Illumina Dividend Chart

Illumina Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Illumina Performance

1 Week
1 Month
6 Months
14.67 %
Year to Date
34.05 %
1 Year
82.50 %
5 Years
180.4 %

Illumina Revenue, EBIT, and Income

Illumina Margins

Illumina Shares Outstanding

Useful Links

Search Twitter: $ILMN, #ILMN

Illumina Company Info

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. has a strategic collaboration with Myriad Genetics, Inc. to create a kit-based version of the myChoice companion diagnostic test for international markets. The company was founded in 1998 and is headquartered in San Diego, California.

Illumina Price to Earnings Ratio (PE Ratio): 89.7

The current Price to Earnings Ratio of Illumina is 89.7.
The PE Ratio is calcluated by dividing the current Illumina share price (493.0 USD) by the earnings per share (4.5).

Illumina Market Cap: 58.2 B USD

The current market cap of Illumina is 58.2 B USD.

Illumina Stock Price: 493.0 USD

The current stock price of Illumina is 493.0 USD.

Illumina ISIN: US4523271090

The ISIN (International Securities Identification Number) of Illumina is US4523271090.

Illumina Ticker Symbol: ILMN

The ticker symbol of Illumina is ILMN.

Illumina Address

The address of the Illumina HQ is 5200 Illumina Way, 92122 San Diego, CA, USA.